Human serum dopamine-I3-hydroxylase[3,4-dihydroxyphenylethylamine, ascorbate:oxygen oxidoreductase (B8-hydroxylating), EC 1.14.17.11 levels have been determined in 52 samples with a newly devised radioimmunoassay that utilizes purified human enzyme and its specific antiserum. The values obtained were in excellent agreement (correlation coefficient r = 0.98) with those obtained by measuring enzymatic activity in the same sera. Either assay technique, enzymatic or homologous radioimmunoassay, can be used for measurement of the enzyme in normal human serum.The evaluation of the usefulness of serum levels of dopamine-,3-hydroxylase [3,4-dihydroxyphenylethylamine, ascorbate: oxygen oxidoreductase (/3-hydroxylating), EC 1.14.17.1, DO3H] as an index of sympathetic nervous system activity in man has been hindered by the extremely wide range of values seen in "normal" human serum samples (1-4). This wide range of values appears to be genetically controlled (5, 6) and may mask any variations due to differences in sympathetic activity. Recently, using a radioimmunoassay developed for bovine DjOH, we measured human serum and compared these values with those obtained by enzyme assay (7). No correlation was found. On the other hand, Ebstein et al. (8), using a radioimmunoassay developed for the enzyme isolated from a human pheochromocytoma, found significant correlation between the enzymatic and immunoassays of individual human sera in one study (8) but not in another one (9). In order to help clarify the relationship between the two types of assay we have estimated individual serum samples by both an enzymatic and a homologous radioimmunoassayt for human D03H. The immunoassay was developed using purified human DOH isolated from adrenal glands obtained at autopsy, and its specific antibody.Abbreviation: D,3H, dopamine-,8-hydroxylase.